Targeted Protein Degradation for Agricultural Applications: Rationale, Challenges, and Outlook.

IF 3.5 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
ACS Bio & Med Chem Au Pub Date : 2025-07-31 eCollection Date: 2025-10-15 DOI:10.1021/acsbiomedchemau.5c00111
Denis Fourches, Joseph Pilotte, Brian E Watts, Daniel J Saltzberg, Robert M Cicchillo
{"title":"Targeted Protein Degradation for Agricultural Applications: Rationale, Challenges, and Outlook.","authors":"Denis Fourches, Joseph Pilotte, Brian E Watts, Daniel J Saltzberg, Robert M Cicchillo","doi":"10.1021/acsbiomedchemau.5c00111","DOIUrl":null,"url":null,"abstract":"<p><p>Farmers urgently need novel technologies to ensure global food security for the rapidly expanding population, yet crop protection has seen little innovation in decades. Mounting regulatory pressures, pest resistance, and environmental concerns are driving demand for novel sustainable solutions. Beyond traditional small molecule active ingredients, very few alternative modalities (<i>e.g</i>., peptides, RNAi, biopesticides) have reached the market. Meanwhile, targeted protein degradation (TPD) has emerged as a breakthrough modality for human therapeutics, with numerous proteolysis-targeting chimeras (PROTACs) and molecular glues (MGs) advancing through clinical trials. Those compounds induce potent and selective degradation of protein targets via the ubiquitin-proteasome system (UPS). Recently, PROTACs have been shown to function in both insect cells and in whole insect organisms, marking a pivotal step toward their use as next-generation crop protection solutions. In this perspective, we showcase the rationale, key challenges, and potential breadth of applications of targeted protein degraders for agricultural purposes. The TPD technology is a promising and potentially disruptive alternative to traditional small molecule inhibitors in agriculture.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 5","pages":"778-791"},"PeriodicalIF":3.5000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531867/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/acsbiomedchemau.5c00111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/15 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Farmers urgently need novel technologies to ensure global food security for the rapidly expanding population, yet crop protection has seen little innovation in decades. Mounting regulatory pressures, pest resistance, and environmental concerns are driving demand for novel sustainable solutions. Beyond traditional small molecule active ingredients, very few alternative modalities (e.g., peptides, RNAi, biopesticides) have reached the market. Meanwhile, targeted protein degradation (TPD) has emerged as a breakthrough modality for human therapeutics, with numerous proteolysis-targeting chimeras (PROTACs) and molecular glues (MGs) advancing through clinical trials. Those compounds induce potent and selective degradation of protein targets via the ubiquitin-proteasome system (UPS). Recently, PROTACs have been shown to function in both insect cells and in whole insect organisms, marking a pivotal step toward their use as next-generation crop protection solutions. In this perspective, we showcase the rationale, key challenges, and potential breadth of applications of targeted protein degraders for agricultural purposes. The TPD technology is a promising and potentially disruptive alternative to traditional small molecule inhibitors in agriculture.

Abstract Image

Abstract Image

Abstract Image

农业应用的靶向蛋白质降解:基本原理、挑战和展望。
农民迫切需要新技术来确保快速增长的人口的全球粮食安全,但几十年来作物保护几乎没有创新。不断增加的监管压力、害虫抗性和环境问题推动了对新型可持续解决方案的需求。除了传统的小分子活性成分,很少有替代方式(如肽、RNAi、生物农药)已经进入市场。与此同时,靶向蛋白降解(TPD)已经成为人类治疗的一种突破性模式,许多靶向蛋白降解嵌合体(PROTACs)和分子胶(mg)正在临床试验中取得进展。这些化合物通过泛素-蛋白酶体系统(UPS)诱导有效和选择性地降解蛋白质目标。最近,PROTACs已被证明在昆虫细胞和整个昆虫有机体中起作用,标志着其作为下一代作物保护解决方案的关键一步。从这个角度来看,我们展示了靶向蛋白质降解剂用于农业目的的基本原理,关键挑战和潜在应用的广度。TPD技术在农业中是传统小分子抑制剂的一种很有前途和潜在破坏性的替代品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Bio & Med Chem Au
ACS Bio & Med Chem Au 药物、生物、化学-
CiteScore
4.10
自引率
0.00%
发文量
0
期刊介绍: ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书